Skip to content

Almax Pharma

Active
Private limited companyfounded 2014active for 12 yearsRue Saint Pierre et Paul(Thy) 10, 5651 Walcourt, BelgiumKBO/BCE: BE 0556.705.368
Summary

Almax Pharma has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €303,429 and a net result of €2,070. Equity is growing by about 8.2% per year across the filed financial years. Its solvency ranks better than 93% of 22,632 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

History

Almax Pharma was incorporated on 17 July 2014.1 Total assets rose from €285,430 in 2019 to €346,656 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2019 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-10-2026
2025
04-11
NBB filing Annual accounts filed
financial year 2025 · micro format · 4 days late
31-03
Financial Weakest financial yearnet €2,070 ▼88.2%
Net result drops to €2,070, the lowest in the series.
2024
23-12
NBB filing Annual accounts filed
financial year 2024 · full format · 53 days late
19-01
Gazette deed Resignation: BROUSMICHE Christine Rita Thérèse (manager)
Appointment: BROUSMICHE Christine Rita Thérèse (director) · Capital conversion · Reserve release12 facts ▸
  • General meeting, “assemblée générale des actionnaires” (deed in French)
  • Other provision, “application du Code des sociétés et des associations, société privée à responsabilité limitée” (deed in French)
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Reserve release, “limitation, compte de capitaux propres statutairement indisponible” (deed in French)
  • Amendment of the articles
  • Capital
  • Power of attorney, Vincent BAELDEN
  • Director resignation, BROUSMICHE Christine Rita Thérèse (manager)
  • Director discharge, BROUSMICHE Christine Rita Thérèse
  • Director appointment, BROUSMICHE Christine Rita Thérèse (director (not named in the articles))
  • Registered office clause, “5651 Thy-le-Château,ville de Walcourt,Rue Saints Pierre et Paul,n°10, SIXIEME RESOLUTION : SIEGE” (deed in French)
  • Power of attorney
2023
10-11
NBB filing Annual accounts filed
financial year 2023 · full format · 10 days late
2022
17-11
NBB filing Annual accounts filed
financial year 2022 · full format · 17 days late
2021
20-08
NBB filing Annual accounts filed
financial year 2021 · micro format
2020
01-09
NBB filing Annual accounts filed
financial year 2020 · micro format
31-03
Financial Equity above €200,000equity €208,082 ▲15.9%
A profit in every financial year since 2019 builds equity to €208,082.
2019
18-11
NBB filing Annual accounts filed
financial year 2019 · micro format · 18 days late
14-02
NBB filing Annual accounts filed
financial year 2018 · micro format · 106 days late
2018
13-11
NBB filing Annual accounts filed
financial year 2017 · micro format · 378 days late
2017
01-02
NBB filing Annual accounts filed
financial year 2016 · full format · 93 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.